Eurocastle Investment (XAMS:ECT) ROCE %: % (As of Dec. 2025)


XAMS:ECT Eurocastle Investment Ltd XAMS:ECT
47 GF Score
Price €13.90
GF Value €4.66
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Eurocastle Investment ROCE %?

Eurocastle Investment XAMS:ECT 47 ROCE % is % as of Dec. 2025. GuruFocus rates XAMS:ECT with a GF Score™ of 47/100 and a GF Value™ of €4.66 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % does not apply to banks and insurance companies.

XAMS:ECT
47GF Score
Eurocastle Investment Ltd XAMS:ECT
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of % mean?
Eurocastle Investment (XAMS:ECT) has a ROCE % of % as of Dec. 2025.
Is Eurocastle Investment's ROCE % too high?
Eurocastle Investment's current ROCE % is %. Overall, Eurocastle Investment has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eurocastle Investment's ROCE % compare to BLK and BX?
Eurocastle Investment's ROCE % of % can be compared against companies in the Asset Management industry. The industry median ROCE % is 4.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Asset Management company?
The median ROCE % among Asset Management companies is 4.46, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Asset Management industry, the median ROCE % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurocastle Investment's current ROCE % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurocastle Investment stock overvalued right now?
Based on GuruFocus' analysis, Eurocastle Investment (XAMS:ECT) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.66, compared to a current price of €13.90 — trading 198.3% above its estimated fair value. The current ROCE % is %. Eurocastle Investment's overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Eurocastle Investment (XAMS:ECT), the current ROCE % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurocastle Investment (XAMS:ECT) Overvalued in 2026?

Based on GuruFocus' analysis, Eurocastle Investment stock appears to be overvalued. The current stock price of €13.90 is trading 198.3% above its estimated GF Value™ of €4.66. GuruFocus considers Eurocastle Investment to be Significantly Overvalued.

Key valuation signals for XAMS:ECT:

  • ROCE %: %
  • GF Value™: €4.66 vs. price of €13.90 (198.3% above fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the XAMS:ECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurocastle Investment Business Description

Address Hirzel Street, Oak House, Saint Peter Port, GGY, GY1 2NP
Eurocastle Investment Ltd is a publicly traded closed-ended investment company. The company focuses on opportunistic real estate investments in Greece and Southern Europe. The portfolio of the company includes residual interests in two Real Estate Funds in liquidation, with remaining assets comprising Net Corporate Cash for new investments. The company's business segments are categorized into New Investment and Legacy Italian Investments. Geographically, the company operates only in Europe.
47GF Score

Get the complete analysis for XAMS:ECT

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€13.90
Price
€4.66
GF Value